$NRGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEUROGEN CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEUROGEN CORP. Get notifications about new insider transactions in NEUROGEN CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 13 2005 | NRGN | NEUROGEN CORP | WOOLSEY SUZANNE | Director | Option Exercise | A | 6.23 | 3,000 | 18,690 | 3,000 | |
Jun 13 2005 | NRGN | NEUROGEN CORP | NOVITCH MARK M D | Director | Option Exercise | A | 6.23 | 5,000 | 31,150 | 5,000 | |
Jun 13 2005 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 6.23 | 5,000 | 31,150 | 5,000 | |
Jun 13 2005 | NRGN | NEUROGEN CORP | BAKER JULIAN | 10% Owner | Option Exercise | A | 6.23 | 5,000 | 31,150 | 5,000 | |
Jun 13 2005 | NRGN | NEUROGEN CORP | LEFF JONATHAN S | Director | Option Exercise | A | 6.23 | 3,000 | 18,690 | 3,000 | |
Jun 13 2005 | NRGN | NEUROGEN CORP | BAKER FELIX | 10% Owner | Option Exercise | A | 6.23 | 3,000 | 18,690 | 3,000 | |
Jun 13 2005 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 6.23 | 4,500 | 28,035 | 4,500 | |
Jun 13 2005 | NRGN | NEUROGEN CORP | BUTLER ROBERT N | Director | Option Exercise | A | 6.23 | 1,500 | 9,345 | 1,500 | |
Jun 13 2005 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 6.23 | 4,500 | 28,035 | 4,500 | |
May 26 2005 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Sell | S | 6.53 | 7,500 | 48,975 | 70,000 | 77.5 K to 70 K (-9.68 %) |
May 25 2005 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Grant | A | 6.86 | 1,539 | 10,558 | 7,341 | 5.8 K to 7.3 K (+26.53 %) |
May 25 2005 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Sell | S | 6.75 | 7,500 | 50,625 | 77,500 | 85 K to 77.5 K (-8.82 %) |
May 25 2005 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Sell | O | 7.01 | 15,000 | 105,150 | 85,000 | 100 K to 85 K (-15.00 %) |
Mar 17 2005 | NRGN | NEUROGEN CORP | BAKER FELIX | Director | Option Exercise | A | 7.36 | 2,500 | 18,400 | 2,500 | |
Mar 17 2005 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 7.36 | 2,500 | 18,400 | 2,500 | |
Mar 16 2005 | NRGN | NEUROGEN CORP | WOOLSEY SUZANNE | Director | Option Exercise | A | 7.36 | 2,500 | 18,400 | 2,500 | |
Mar 16 2005 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 7.36 | 2,500 | 18,400 | 2,500 | |
Mar 16 2005 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 7.36 | 2,500 | 18,400 | 2,500 | |
Mar 16 2005 | NRGN | NEUROGEN CORP | NOVITCH MARK M D | Director | Option Exercise | A | 7.36 | 2,500 | 18,400 | 2,500 | |
Mar 16 2005 | NRGN | NEUROGEN CORP | LEFF JONATHAN S | Director | Option Exercise | A | 7.36 | 2,500 | 18,400 | 2,500 | |
Mar 16 2005 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 7.36 | 2,500 | 18,400 | 2,500 | |
Mar 16 2005 | NRGN | NEUROGEN CORP | BUTLER ROBERT N | Director | Option Exercise | A | 7.36 | 2,500 | 18,400 | 2,500 | |
Mar 16 2005 | NRGN | NEUROGEN CORP | CARLUCCI FRANK C | Director | Option Exercise | A | 7.36 | 2,500 | 18,400 | 2,500 | |
Mar 16 2005 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 7.36 | 2,500 | 18,400 | 2,500 | |
Mar 16 2005 | NRGN | NEUROGEN CORP | BUTLER ROBERT N | Director | Option Exercise | A | 7.36 | 2,500 | 18,400 | 2,500 | |
Dec 29 2004 | NRGN | NEUROGEN CORP | BUTLER ROBERT N | Director | Option Exercise | M | 6.50 | 2,776 | 18,044 | 0 | |
Dec 29 2004 | NRGN | NEUROGEN CORP | BUTLER ROBERT N | Director | Sell | S | 9.15 | 2,776 | 25,400 | 2,000 | 4.8 K to 2 K (-58.12 %) |
Dec 29 2004 | NRGN | NEUROGEN CORP | BUTLER ROBERT N | Director | Buy | M | 6.50 | 2,776 | 18,044 | 0 | -2,776 to 0 (-100.00 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Busine ... | Option Exercise | M | 3.87 | 12 | 46 | 0 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Busine ... | Option Exercise | M | 3.87 | 17,488 | 67,679 | 0 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Busine ... | Option Exercise | A | 9.05 | 100,000 | 905,000 | 100,000 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Busine ... | Grant | A | 9.15 | 487 | 4,456 | 5,979 | 5.5 K to 6 K (+8.87 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Busine ... | Sell | S | 9.55 | 12 | 115 | 50,750 | 50.8 K to 50.8 K (-0.02 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Busine ... | Buy | M | 3.87 | 12 | 46 | 0 | -12 to 0 (-100.00 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Busine ... | Sell | S | 9.00 | 17,488 | 157,392 | 0 | 17.5 K to 0 (-100.00 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Busine ... | Buy | M | 3.87 | 17,488 | 67,679 | 0 | -17,488 to 0 (-100.00 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Option Exercise | M | 6.50 | 24,000 | 156,000 | 0 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Option Exercise | M | 6.50 | 3,500 | 22,750 | 0 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Option Exercise | M | 6.50 | 1,000 | 6,500 | 0 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Option Exercise | M | 6.50 | 6,482 | 42,133 | 0 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Option Exercise | A | 9.05 | 28,000 | 253,400 | 0 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Grant | A | 9.15 | 1,427 | 13,057 | 5,802 | 4.4 K to 5.8 K (+32.62 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Sell | S | 8.97 | 24,000 | 215,280 | 100,000 | 124 K to 100 K (-19.35 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Buy | M | 6.50 | 24,000 | 156,000 | 0 | -24,000 to 0 (-100.00 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Sell | S | 9.31 | 3,500 | 32,585 | 0 | 3.5 K to 0 (-100.00 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Buy | M | 6.50 | 3,500 | 22,750 | 0 | -3,500 to 0 (-100.00 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Sell | S | 9.30 | 1,000 | 9,300 | 0 | 1,000 to 0 (-100.00 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Buy | M | 6.50 | 1,000 | 6,500 | 0 | -1,000 to 0 (-100.00 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Sell | S | 9.15 | 6,482 | 59,310 | 0 | 6.5 K to 0 (-100.00 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Buy | M | 6.50 | 6,482 | 42,133 | 0 | -6,482 to 0 (-100.00 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | NOVITCH MARK M D | Director | Option Exercise | M | 6.50 | 5,000 | 32,500 | 0 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | NOVITCH MARK M D | Director | Payment of Exercise | F | 9.05 | 3,591 | 32,499 | 35,409 | 39 K to 35.4 K (-9.21 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | NOVITCH MARK M D | Director | Buy | M | 6.50 | 5,000 | 32,500 | 0 | -5,000 to 0 (-100.00 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 9.05 | 75,000 | 678,750 | 0 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Grant | A | 9.05 | 25,000 | 226,250 | 25,000 | 0 to 25 K |
Dec 23 2004 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | M | 6.50 | 5,000 | 32,500 | 0 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Sell | M | 6.50 | 5,000 | 32,500 | 58,504 | 63.5 K to 58.5 K (-7.87 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | KOSTER WILLIAM H | President, CEO | Option Exercise | A | 9.05 | 120,000 | 1,086,000 | 120,000 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | Ritrovato Charles | SR VP Drug Regulato ... | Option Exercise | A | 9.05 | 24,000 | 217,200 | 24,000 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | LEE LAI FOON | Vice President Fina ... | Option Exercise | A | 9.05 | 20,000 | 181,000 | 20,000 | |
Dec 17 2004 | NRGN | NEUROGEN CORP | BAKER FELIX | Director | Option Exercise | A | 9.14 | 1,535 | 14,030 | 1,535 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | KRAUSE JAMES | Senior VP Biology | Option Exercise | A | 9.05 | 24,000 | 217,200 | 24,000 | |
Dec 17 2004 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 9.14 | 1,535 | 14,030 | 1,535 | |
Dec 16 2004 | NRGN | NEUROGEN CORP | NOVITCH MARK M D | Director | Option Exercise | A | 9.14 | 2,500 | 22,850 | 2,500 | |
Dec 16 2004 | NRGN | NEUROGEN CORP | BUTLER ROBERT N | Director | Option Exercise | A | 9.14 | 727 | 6,645 | 727 | |
Dec 16 2004 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 9.14 | 809 | 7,394 | 809 | |
Dec 16 2004 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 9.14 | 1,754 | 16,032 | 1,754 | |
Dec 16 2004 | NRGN | NEUROGEN CORP | LEFF JONATHAN S | Director | Option Exercise | A | 9.14 | 2,042 | 18,664 | 2,042 | |
Dec 16 2004 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 9.14 | 2,042 | 18,664 | 2,042 | |
Dec 16 2004 | NRGN | NEUROGEN CORP | CARLUCCI FRANK C | Director | Option Exercise | M | 6.50 | 5,000 | 32,500 | 0 | |
Dec 16 2004 | NRGN | NEUROGEN CORP | CARLUCCI FRANK C | Director | Option Exercise | A | 9.14 | 2,500 | 22,850 | 2,500 | |
Dec 16 2004 | NRGN | NEUROGEN CORP | CARLUCCI FRANK C | Director | Buy | M | 9.14 | 5,000 | 45,700 | 131,325 | 126.3 K to 131.3 K (+3.96 %) |
Dec 16 2004 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 9.14 | 2,500 | 22,850 | 2,500 | |
Dec 16 2004 | NRGN | NEUROGEN CORP | WOOLSEY SUZANNE | Director | Option Exercise | A | 9.14 | 2,500 | 22,850 | 2,500 | |
Nov 02 2004 | NRGN | NEUROGEN CORP | BAKER BIOTECH CAPITAL II GP LL ... | Director | Sell | J | 0.00 | 268,465 | 0 | 2,039,196 | 2.3 M to 2 M (-11.63 %) |
Sep 17 2004 | NRGN | NEUROGEN CORP | NOVITCH MARK M D | Director | Option Exercise | A | 6.35 | 1,062 | 6,744 | 1,062 | |
Sep 17 2004 | NRGN | NEUROGEN CORP | CARLUCCI FRANK C | Director | Option Exercise | A | 6.35 | 610 | 3,874 | 610 | |
Sep 17 2004 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 6.35 | 747 | 4,743 | 747 | |
Sep 17 2004 | NRGN | NEUROGEN CORP | WOOLSEY SUZANNE | Director | Option Exercise | A | 6.35 | 1,021 | 6,483 | 1,021 | |
Jul 28 2004 | NRGN | NEUROGEN CORP | BAKER FELIX | Director | Option Exercise | A | 6.65 | 3,000 | 19,950 | 3,000 | |
Jul 28 2004 | NRGN | NEUROGEN CORP | BAKER FELIX | Director | Option Exercise | A | 6.65 | 3,000 | 19,950 | 3,000 | |
Jul 28 2004 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 6.65 | 5,000 | 33,250 | 5,000 | |
Jul 28 2004 | NRGN | NEUROGEN CORP | WOOLSEY SUZANNE | Director | Option Exercise | A | 6.65 | 3,000 | 19,950 | 3,000 | |
Jul 28 2004 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 6.65 | 5,000 | 33,250 | 5,000 | |
Jul 28 2004 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 6.65 | 5,000 | 33,250 | 5,000 | |
Jul 28 2004 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 6.65 | 2,500 | 16,625 | 2,500 | |
Jul 28 2004 | NRGN | NEUROGEN CORP | LEFF JONATHAN S | Director | Option Exercise | A | 6.65 | 3,000 | 19,950 | 3,000 | |
Jul 28 2004 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 6.65 | 4,500 | 29,925 | 4,500 | |
Jul 28 2004 | NRGN | NEUROGEN CORP | CARLUCCI FRANK C | Director | Option Exercise | A | 6.65 | 5,000 | 33,250 | 5,000 | |
Jul 28 2004 | NRGN | NEUROGEN CORP | NOVITCH MARK M D | Director | Option Exercise | A | 6.65 | 5,000 | 33,250 | 5,000 | |
Jul 28 2004 | NRGN | NEUROGEN CORP | BUTLER ROBERT N | Director | Option Exercise | A | 6.65 | 1,500 | 9,975 | 1,500 | |
Jul 28 2004 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 6.65 | 4,500 | 29,925 | 4,500 | |
Jul 28 2004 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 6.65 | 4,500 | 29,925 | 4,500 | |
Jul 27 2004 | NRGN | NEUROGEN CORP | BUTLER ROBERT N | Director | Option Exercise | A | 6.23 | 5,000 | 31,150 | 5,000 | |
Jul 20 2004 | NRGN | NEUROGEN CORP | BROSHY ERAN | Director | Option Exercise | A | 6.39 | 5,000 | 31,955 | 5,000 | |
May 27 2004 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 9.18 | 5,000 | 45,900 | 5,000 | |
May 27 2004 | NRGN | NEUROGEN CORP | BAKER FELIX | Director | Option Exercise | A | 9.18 | 5,000 | 45,900 | 5,000 | |
May 25 2004 | NRGN | NEUROGEN CORP | LEE LAI FOON | Vice President Fina ... | Option Exercise | A | 9.50 | 22,500 | 213,750 | 0 | |
May 25 2004 | NRGN | NEUROGEN CORP | Ritrovato Charles | Sr VP Drug Regulato ... | Option Exercise | A | 9.50 | 50,000 | 475,000 | 0 | |
May 25 2004 | NRGN | NEUROGEN CORP | KRAUSE JAMES | Senior VP Biology | Option Exercise | A | 9.50 | 50,000 | 475,000 | 0 | |
May 25 2004 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Option Exercise | A | 9.50 | 50,000 | 475,000 | 0 | |
May 25 2004 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Grant | A | 0.00 | 50,000 | 0 | 100,000 | 50 K to 100 K (+100.00 %) |
May 11 2004 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 9.72 | 5,000 | 48,600 | 0 | |
May 03 2004 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 4.25 | 4,000 | 17,000 | 4,000 | |
May 03 2004 | NRGN | NEUROGEN CORP | BAKER FELIX | Director | Option Exercise | A | 11.83 | 5,000 | 59,150 | 5,000 | |
May 03 2004 | NRGN | NEUROGEN CORP | BAKER FELIX | Director | Option Exercise | A | 9.99 | 4,500 | 44,955 | 4,500 | |
May 03 2004 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 9.99 | 4,000 | 39,960 | 4,000 | |
May 03 2004 | NRGN | NEUROGEN CORP | BAKER JULIAN | Director | Option Exercise | A | 11.83 | 5,000 | 59,150 | 5,000 | |
May 03 2004 | NRGN | NEUROGEN CORP | BAKER FELIX | Director | Option Exercise | A | 4.25 | 4,500 | 19,125 | 4,500 | |
Apr 28 2004 | NRGN | NEUROGEN CORP | BLOOM BARRY | Director | Option Exercise | A | 4.25 | 4,000 | 17,000 | 4,000 | |
Apr 28 2004 | NRGN | NEUROGEN CORP | BUTLER ROBERT N | Director | Option Exercise | A | 4.25 | 1,500 | 6,375 | 1,500 | |
Apr 28 2004 | NRGN | NEUROGEN CORP | CARLUCCI FRANK C | Director | Option Exercise | A | 4.25 | 5,000 | 21,250 | 5,000 | |
Apr 28 2004 | NRGN | NEUROGEN CORP | NOVITCH MARK M D | Director | Option Exercise | A | 4.25 | 3,000 | 12,750 | 3,000 | |
Apr 28 2004 | NRGN | NEUROGEN CORP | SAXTON CRAIG | Director | Option Exercise | A | 4.25 | 1,500 | 6,375 | 1,500 | |
Apr 28 2004 | NRGN | NEUROGEN CORP | SIMON JOHN | Director | Option Exercise | A | 4.25 | 5,000 | 21,250 | 5,000 | |
Apr 28 2004 | NRGN | NEUROGEN CORP | WOOLSEY SUZANNE | Director | Option Exercise | A | 4.25 | 1,500 | 6,375 | 1,500 | |
Apr 21 2004 | NRGN | NEUROGEN CORP | TISCH JAMES S | 10% Owner | Buy | P | 7.00 | 267,858 | 1,875,006 | 947,108 | 679.3 K to 947.1 K (+39.43 %) |
Apr 21 2004 | NRGN | NEUROGEN CORP | TISCH THOMAS J | 10% Owner | Buy | P | 7.00 | 267,858 | 1,875,006 | 1,247,108 | 979.3 K to 1.2 M (+27.35 %) |
Apr 21 2004 | NRGN | NEUROGEN CORP | TISCH DANIEL R | 10% Owner | Buy | P | 7.00 | 267,858 | 1,875,006 | 947,108 | 679.3 K to 947.1 K (+39.43 %) |
Apr 21 2004 | NRGN | NEUROGEN CORP | TISCH ANDREW H | 10% Owner | Buy | P | 7.00 | 267,858 | 1,875,006 | 947,108 | 679.3 K to 947.1 K (+39.43 %) |
Apr 21 2004 | NRGN | NEUROGEN CORP | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Buy | P | 7.00 | 2,241,286 | 15,689,002 | 2,307,661 | 66.4 K to 2.3 M (+3,376.70 %) |
Apr 21 2004 | NRGN | NEUROGEN CORP | BAKER TISCH CAPITAL GP LLC | Director | Buy | P | 7.00 | 203,935 | 1,427,545 | 371,490 | 167.6 K to 371.5 K (+121.71 %) |
Apr 21 2004 | NRGN | NEUROGEN CORP | BAKER BROS CAPITAL GP LLC | 10% Owner | Buy | P | 7.00 | 281,754 | 1,972,278 | 451,339 | 169.6 K to 451.3 K (+166.14 %) |
Apr 21 2004 | NRGN | NEUROGEN CORP | BAKER BIOTECH CAPITAL GP LLC | Director | Buy | P | 7.00 | 1,915,924 | 13,411,468 | 2,195,509 | 279.6 K to 2.2 M (+685.27 %) |
Apr 21 2004 | NRGN | NEUROGEN CORP | LEFF JONATHAN S | Director | Option Exercise | A | 9.35 | 20,000 | 187,000 | 20,000 | |
Apr 21 2004 | NRGN | NEUROGEN CORP | HEN STEWART | Director | Option Exercise | A | 9.35 | 20,000 | 187,000 | 20,000 | |
Apr 02 2004 | NRGN | NEUROGEN CORP | BUTLER ROBERT N | Director | Sell | S | 8.70 | 1,632 | 14,198 | 2,000 | 3.6 K to 2 K (-44.93 %) |
Apr 02 2004 | NRGN | NEUROGEN CORP | BUTLER ROBERT N | Director | Sell | S | 8.71 | 500 | 4,355 | 3,632 | 4.1 K to 3.6 K (-12.10 %) |
Apr 02 2004 | NRGN | NEUROGEN CORP | BUTLER ROBERT N | Director | Sell | S | 8.74 | 300 | 2,622 | 4,132 | 4.4 K to 4.1 K (-6.77 %) |
Feb 02 2004 | NRGN | NEUROGEN CORP | CARLUCCI FRANK C | Director | Option Exercise | A | 8.56 | 5,000 | 42,800 | 5,000 | |
Dec 18 2003 | NRGN | NEUROGEN CORP | HUTCHISON ALAN | Exec VP Discovery R ... | Option Exercise | A | 8.79 | 31,500 | 276,885 | 31,500 | |
Dec 18 2003 | NRGN | NEUROGEN CORP | KRAUSE JAMES | Senior VP Biology | Option Exercise | A | 8.79 | 27,000 | 237,330 | 27,000 | |
Dec 18 2003 | NRGN | NEUROGEN CORP | KRAUSE JAMES | Senior VP Biology | Option Exercise | A | 8.79 | 27,000 | 237,330 | 27,000 | |
Dec 18 2003 | NRGN | NEUROGEN CORP | KRAUSE JAMES | Senior VP Biology | Option Exercise | A | 8.79 | 27,000 | 237,330 | 27,000 | |
Dec 18 2003 | NRGN | NEUROGEN CORP | KOSTER WILLIAM H | President, CEO | Option Exercise | A | 8.79 | 54,000 | 474,660 | 54,000 |